Skip to main content

Table 3 TNM stage-stratified analysis between CFP1 and 14-3-3 expression and overall survival time in 660 GC tissues

From: The survival analysis and oncogenic effects of CFP1 and 14-3-3 expression on gastric cancer

Item

No. (%)

Median survival time, mo (95% confidence interval)

P

Stage I

 CFP1 low expression

47 (70.1)

–

0.0301

 CFP1 high expression

20 (29.9)

–

 14-3-3 low expression

49 (73.1)

93.2

0.0190

 14-3-3 high expression

18 (26.9)

–

Stage II

 CFP1 low expression

99 (70.7)

–

0.0317

 CFP1 high expression

41 (29.3)

123.6

 14-3-3 low expression

46 (32.9)

123.6

0.0258

 14-3-3 high expression

94 (67.1)

123.8

Stage III

 CFP1 low expression

214 (70.2)

89.43

< 0.0001

 CFP1 high expression

91 (29.8)

24.5

 14-3-3 low expression

101 (33.1)

25.9

0.0015

 14-3-3 high expression

204 (66.9)

47.7

Stage IV

 CFP1 low expression

81 (54.7)

20.03

0.0386

 CFP1 high expression

67 (45.3)

14.3

 14-3-3 low expression

108 (73.0)

11.4

0.0032

 14-3-3 high expression

40 (27.0)

20.03